1-3 of 3
Rozemarijn S. van Rijn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry

Rik J. Verheijden, Anne M. May, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Alfonsus J.M. van den Eertwegh, Jan Willem B. de Groot, Marye J. Boers-Sonderen, Jacobus J.M. van der Hoeven, Geke A. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Albert J. ten Tije, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Michiel C.T. van Zeijl, Michel W.J.M. Wouters, John B.A.G. Haanen, Ellen Kapiteijn, Karijn P.M. Suijkerbuijk
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (9): 2268–2274.
https://doi.org/10.1158/1078-0432.CCR-19-3322
Published: 01 May 2020
View article titled, Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry
Open the PDF for Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry in another window
Includes: Supplementary data
Journal Articles

Human Regulatory T Cells Control Xenogeneic Graft-versus-Host Disease Induced by Autologous T Cells in RAG2−/−γc−/− Immunodeficient Mice

Tuna Mutis, Rozemarijn S. van Rijn, Elles R. Simonetti, Tineke Aarts-Riemens, Maarten E. Emmelot, Louis van Bloois, Anton Martens, Leo F. Verdonck, Saskia B. Ebeling
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5520–5525.
https://doi.org/10.1158/1078-0432.CCR-06-0035
Published: 25 September 2006
View article titled, Human Regulatory T Cells Control Xenogeneic Graft-versus-Host Disease Induced by Autologous T Cells in RAG2<sup>−/−</sup>γc<sup>−/−</sup> Immunodeficient Mice
Open the PDF for Human Regulatory T Cells Control Xenogeneic Graft-versus-Host Disease Induced by Autologous T Cells in RAG2<sup>−/−</sup>γc<sup>−/−</sup> Immunodeficient Mice in another window
Journal Articles

Complement-Induced Cell Death by Rituximab Depends on CD20 Expression Level and Acts Complementary to Antibody-Dependent Cellular Cytotoxicity

Tom van Meerten, Rozemarijn S. van Rijn, Samantha Hol, Anton Hagenbeek, Saskia B. Ebeling
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 4027–4035.
https://doi.org/10.1158/1078-0432.CCR-06-0066
Published: 03 July 2006
View article titled, Complement-Induced Cell Death by Rituximab Depends on CD20 Expression Level and Acts Complementary to Antibody-Dependent Cellular Cytotoxicity
Open the PDF for Complement-Induced Cell Death by Rituximab Depends on CD20 Expression Level and Acts Complementary to Antibody-Dependent Cellular Cytotoxicity in another window